Meeting
2018 Gastrointestinal Cancers Symposium
The impact of chronic kidney disease in locally advanced rectal cancer patients treated with neoadjuvant chemoradiation.
Authors
Shaan Dudani
Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, Canada
Shaan Dudani , Horia Marginean , Joanna Gotfrit , Patricia A. Tang , Jose Gerard Monzon , Kristopher Dennis , Hagen F. Kennecke , Erin Diana Powell , Sam Babak , Winson Y. Cheung , Michael M. Vickers
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 794)
DOI
10.1200/JCO.2018.36.4_suppl.794
Abstract #
794
Poster Bd #
L17
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Survival outcome and treatment response of patients with young-onset locally advanced rectal cancer (YO-LARC) receiving total neoadjuvant therapy (TNT).
First Author: Edward McKenna
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2015 Gastrointestinal Cancers Symposium
Analysis of recurrence pattern and survival in locally advanced rectal cancer treated with neoadjuvant chemoradiation and surgery: 25 years of experience.
First Author: Javier A. Cienfuegos
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.
First Author: Meng Wang